Skip to main content
TryTrutide
Evidence Review

Retatrutide Stacks: Evidence vs Anecdote

Online communities discuss many retatrutide combinations. This page provides a clear evidence status for each commonly discussed stack, distinguishing clinical evidence from anecdotal reports.

Bottom line: No published clinical trial has studied retatrutide combined with any of the compounds below. All combination use is anecdotal. Retatrutide is not FDA approved. This content is educational only.

Retatrutide + Testosterone/TRT
E
No human evidence
Anecdotal use in bodybuilding communities. TRIUMPH trials excluded anabolic steroid users.
Retatrutide + Anavar (Oxandrolone)
E
No human evidence
Anecdotal. Hepatotoxicity risk from oxandrolone is a significant concern.
Retatrutide + RAD-140
E
No human evidence
Anecdotal. RAD-140 not FDA approved; hepatotoxicity case reports exist.
Retatrutide + CJC-1295
E
No human evidence
Anecdotal. CJC-1295 not FDA approved.
Retatrutide + Ipamorelin
E
No human evidence
Anecdotal. Ipamorelin not FDA approved.
Retatrutide + HGH
E
No human evidence
Anecdotal. HGH approved only for specific medical indications; non-medical use is illegal.
Retatrutide + MK-677
E
No human evidence
Anecdotal. MK-677 appetite-stimulating effects may counteract retatrutide.
Retatrutide + BPC-157
X
No human evidence (BPC-157 has no human trial data)
Anecdotal. BPC-157 has no human clinical trial data at all.
Retatrutide + Tesamorelin
E
No human evidence for combination
Tesamorelin is FDA-approved for HIV lipodystrophy only; off-label use is not supported.
Retatrutide + MOTS-c
E
No human evidence
Anecdotal. MOTS-c has minimal human data.
Retatrutide + AOD-9604
E
No human evidence; AOD-9604 failed Phase 3
AOD-9604 failed its Phase 3 obesity trials. Limited additional benefit expected.
Retatrutide + HCG (weight loss)
X
No evidence; HCG diet debunked
FDA has banned HCG weight-loss products. HCG adds no weight-loss benefit beyond caloric restriction.
Retatrutide + SARMs
E
No human evidence
Anecdotal. No SARM is FDA approved. FDA has warned about SARM safety risks.

Evidence ratings: E = Anecdotal (self-reported, not clinical evidence). X = Unsupported or associated with documented safety risks. See Evidence Methodology for full rating definitions.

Questions about retatrutide? A licensed physician can review your case.

Start Physician Review
Related Reading